InflaRx NV (IFRX)
1.32
-0.12
(-8.33%)
USD |
NASDAQ |
Oct 16, 16:00
1.32
0.00 (0.00%)
After-Hours: 20:00
InflaRx Net Income (TTM) : -49.59M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -49.59M |
| March 31, 2026 | -45.96M |
| September 30, 2025 | -58.59M |
| June 30, 2025 | -59.17M |
| March 31, 2025 | -53.31M |
| September 30, 2024 | -61.69M |
| June 30, 2024 | -50.62M |
| March 31, 2024 | -44.65M |
| December 31, 2023 | -46.06M |
| September 30, 2023 | -37.11M |
| June 30, 2023 | -36.98M |
| March 31, 2023 | -27.56M |
| December 31, 2022 | -31.37M |
| September 30, 2022 | -37.67M |
| June 30, 2022 | -43.90M |
| March 31, 2022 | -62.22M |
| December 31, 2021 | -53.89M |
| Date | Value |
|---|---|
| September 30, 2021 | -49.97M |
| June 30, 2021 | -43.78M |
| March 31, 2021 | -37.00M |
| December 31, 2020 | -38.70M |
| September 30, 2020 | -43.24M |
| June 30, 2020 | -51.35M |
| March 31, 2020 | -57.46M |
| December 31, 2019 | -59.56M |
| September 30, 2019 | -56.18M |
| June 30, 2019 | -47.94M |
| March 31, 2019 | -33.69M |
| December 31, 2018 | -35.21M |
| September 30, 2018 | -37.27M |
| June 30, 2018 | -34.16M |
| March 31, 2018 | -36.40M |
| December 31, 2017 | -27.75M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| MediGene AG | -- |
| BioNTech SE | -1.965B |
| Immatics NV | -240.92M |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |